位置:首页 > 蛋白库 > AMPD_CITFR
AMPD_CITFR
ID   AMPD_CITFR              Reviewed;         187 AA.
AC   P82974; Q00831;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2001, sequence version 1.
DT   03-AUG-2022, entry version 101.
DE   RecName: Full=1,6-anhydro-N-acetylmuramyl-L-alanine amidase AmpD {ECO:0000305};
DE            EC=3.5.1.28 {ECO:0000269|PubMed:14507260};
DE   AltName: Full=N-acetylmuramoyl-L-alanine amidase {ECO:0000305};
GN   Name=ampD {ECO:0000303|PubMed:8383940};
OS   Citrobacter freundii.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Citrobacter; Citrobacter freundii complex.
OX   NCBI_TaxID=546;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=OS60;
RX   PubMed=8383940; DOI=10.1128/aac.37.2.224;
RA   Kopp U., Wiedemann B., Lindquist S., Normark S.;
RT   "Sequences of wild-type and mutant ampD genes of Citrobacter freundii and
RT   Enterobacter cloacae.";
RL   Antimicrob. Agents Chemother. 37:224-228(1993).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION, AND
RP   MUTAGENESIS OF HIS-34; TYR-63; GLU-116; HIS-154; LYS-162 AND ASP-164.
RX   PubMed=14507260; DOI=10.1042/bj20030862;
RA   Genereux C., Dehareng D., Devreese B., Van Beeumen J., Frere J.M.,
RA   Joris B.;
RT   "Mutational analysis of the catalytic centre of the Citrobacter freundii
RT   AmpD N-acetylmuramyl-L-alanine amidase.";
RL   Biochem. J. 377:111-120(2004).
RN   [3]
RP   STRUCTURE BY NMR, ZINC-BINDING SITES, AND COFACTOR.
RX   PubMed=12654266; DOI=10.1016/s0022-2836(03)00185-2;
RA   Liepinsh E., Genereux C., Dehareng D., Joris B., Otting G.;
RT   "NMR structure of Citrobacter freundii AmpD, comparison with bacteriophage
RT   T7 lysozyme and homology with PGRP domains.";
RL   J. Mol. Biol. 327:833-842(2003).
CC   -!- FUNCTION: Involved in cell wall peptidoglycan recycling
CC       (PubMed:14507260). Specifically cleaves the amide bond between the
CC       lactyl group of N-acetylmuramic acid and the alpha-amino group of the
CC       L-alanine in degradation products containing an anhydro N-acetylmuramyl
CC       moiety (PubMed:14507260). Is also involved in beta-lactamase induction
CC       (PubMed:8383940). {ECO:0000269|PubMed:14507260,
CC       ECO:0000269|PubMed:8383940}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolyzes the link between N-acetylmuramoyl residues and L-
CC         amino acid residues in certain cell-wall glycopeptides.; EC=3.5.1.28;
CC         Evidence={ECO:0000269|PubMed:14507260};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:12654266, ECO:0000269|PubMed:14507260};
CC       Note=Zn(2+) is required for amidase activity.
CC       {ECO:0000269|PubMed:14507260};
CC   -!- ACTIVITY REGULATION: Amidase activity is inhibited by metal chelators
CC       such as EDTA, dipicolinic acid or 1,10-phenanthroline.
CC       {ECO:0000269|PubMed:14507260}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the N-acetylmuramoyl-L-alanine amidase 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z14002; CAA78390.2; -; Genomic_DNA.
DR   RefSeq; WP_003018719.1; NZ_VTEC01000028.1.
DR   PDB; 1J3G; NMR; -; A=1-187.
DR   PDB; 2Y28; X-ray; 1.80 A; A/B/C=1-187.
DR   PDB; 2Y2B; X-ray; 1.90 A; A/B/C=1-187.
DR   PDB; 2Y2C; X-ray; 1.80 A; A/B/C=1-187.
DR   PDB; 2Y2D; X-ray; 2.00 A; A/B/C=1-187.
DR   PDB; 2Y2E; X-ray; 2.00 A; A/B/C=1-187.
DR   PDBsum; 1J3G; -.
DR   PDBsum; 2Y28; -.
DR   PDBsum; 2Y2B; -.
DR   PDBsum; 2Y2C; -.
DR   PDBsum; 2Y2D; -.
DR   PDBsum; 2Y2E; -.
DR   AlphaFoldDB; P82974; -.
DR   BMRB; P82974; -.
DR   SMR; P82974; -.
DR   STRING; 1333848.CFNIH1_10245; -.
DR   OrthoDB; 1584918at2; -.
DR   EvolutionaryTrace; P82974; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; IDA:CACAO.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro.
DR   CDD; cd06583; PGRP; 1.
DR   Gene3D; 3.40.80.10; -; 1.
DR   InterPro; IPR036505; Amidase/PGRP_sf.
DR   InterPro; IPR002502; Amidase_domain.
DR   Pfam; PF01510; Amidase_2; 1.
DR   SMART; SM00644; Ami_2; 1.
DR   SUPFAM; SSF55846; SSF55846; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell wall biogenesis/degradation; Cytoplasm; Hydrolase;
KW   Metal-binding; Zinc.
FT   CHAIN           1..187
FT                   /note="1,6-anhydro-N-acetylmuramyl-L-alanine amidase AmpD"
FT                   /id="PRO_0000164411"
FT   DOMAIN          30..167
FT                   /note="N-acetylmuramoyl-L-alanine amidase"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        116
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P75820"
FT   BINDING         34
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:12654266"
FT   BINDING         154
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:12654266"
FT   BINDING         164
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:12654266"
FT   SITE            162
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P75820"
FT   MUTAGEN         34
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14507260"
FT   MUTAGEN         63
FT                   /note="Y->F: 6-fold decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:14507260"
FT   MUTAGEN         116
FT                   /note="E->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14507260"
FT   MUTAGEN         154
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14507260"
FT   MUTAGEN         154
FT                   /note="H->N: Retains both its capacity to bind the zinc ion
FT                   and good amidase activity."
FT                   /evidence="ECO:0000269|PubMed:14507260"
FT   MUTAGEN         162
FT                   /note="K->H,Q: Almost loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14507260"
FT   MUTAGEN         164
FT                   /note="D->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14507260"
FT   STRAND          11..13
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   HELIX           23..25
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          30..36
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   HELIX           47..52
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   HELIX           62..67
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          75..78
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   TURN            80..82
FT                   /evidence="ECO:0007829|PDB:1J3G"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          100..102
FT                   /evidence="ECO:0007829|PDB:1J3G"
FT   HELIX           108..111
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          112..119
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          121..123
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   HELIX           127..143
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   HELIX           145..149
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   STRAND          151..153
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   HELIX           154..157
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   TURN            159..161
FT                   /evidence="ECO:0007829|PDB:2Y28"
FT   TURN            164..168
FT                   /evidence="ECO:0007829|PDB:2Y2D"
FT   HELIX           171..177
FT                   /evidence="ECO:0007829|PDB:2Y28"
SQ   SEQUENCE   187 AA;  20847 MW;  DE3B49DBA20562AB CRC64;
     MLLDEGWLAE ARRVPSPHYD CRPDDENPSL LVVHNISLPP GEFGGPWIDA LFTGTIDPNA
     HPYFAGIAHL RVSAHCLIRR DGEIVQYVPF DKRAWHAGVS SYQGRERCND FSIGIELEGT
     DTLAYTDAQY QQLAAVTNAL ITRYPAIANN MTGHCNIAPE RKTDPGPSFD WARFRALVTP
     SSHKEMT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024